Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Cannabis

Cannabis

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cannabis
  • Government
  • Markets
  • News
  • Penny Stocks
  • Regulations

Lobbyists Double Down Prior To Midterms: Will SAFE Banking For Cannabis Companies Benefit?

By Nicolas Jose Rodriguez
September 17, 6:25 PM
Members of the National Cannabis Industry Association (NCIA), the oldest and largest trade association serving the industry, spent two days lobbying on behalf of the SAFE Banking Act, which would provide cannabis companies access to traditional banking services,

HITI

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson’s Disease

By Nicolas Jose Rodriguez
September 17, 6:09 PM
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM), a leader in specialty ketamine pharmaceuticals, announced Friday that the Phase 1/2 clinical study of ketamine in the treatment of levodopa-induced dyskinesia in Parkinson’s disease was presented at the MDS

CSE:PHRM

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details

By Lara Goldstein
September 17, 6:05 PM
Canadian-based psychedelics company Nova Mentis Life Science Corp.

NMLSF

Read More
2 minute read
  • Cannabis
  • Earnings
  • Guidance
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Awakn Shares Its Q2 2022 Results, Showing Consistent Growth On Its Second Full Financial Year

By Lara Goldstein
September 17, 6:01 PM
Biotech firm leading the Alcohol Use Disorder (AUD) treatment Awakn Life Sciences Corp. (OTCQB: AWKNF) has announced its financial outcomes and business highlights for the three months ended July 31, 2022. During the period, numbers reflected:

AWKNF

Read More
2 minute read
  • Cannabis
  • Entrepreneurship
  • General
  • Markets
  • Movers & Shakers
  • News
  • Penny Stocks
  • Small Cap

Former Crime Analyst To Lead Michigan Cannabis Agency & Latest Key Executive Changes In Marijuana Space

By Jelena Martinovic
September 17, 5:29 PM
Former Crime Analyst To Lead Michigan Cannabis Agency

CGC

Read More
2 minute read
  • Cannabis
  • Earnings
  • Guidance
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Wellbeing Digital Reports 4Q Finances, ‘Three Key Pillars’ Stay Strong

By Lara Goldstein
September 16, 4:05 PM
Wellbeing Digital Sciences Inc. (OTC: KONEF) filed its financial results for the quarter ended July 31, 2022 and provided some insight on their most recent businesses. Numbers for the selected period showed:

KONEF

Read More
2 minute read
  • Cannabis
  • Entertainment
  • Events
  • Exclusives
  • General
  • Markets
  • Media
  • News
  • Topics

EXCLUSIVE: This Blue’s Brothers Actor Is Going Green, But Not In The Way You’d Think

By AJ Fabino
September 16, 3:53 PM
Jim Belushi has built a renowned career as an actor, comedian, singer and dancer throughout the course of his more than four-decade career. However, he has another passion that many of his fans are likely unaware: he is a legal cannabis farmer.

WBD

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction

By Lara Goldstein
September 16, 3:10 PM
Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) is advancing its first Phase I/II clinical trial of oral psilocybin for methamphetamine use disorder treatment while also developing an oral psilocybin thin film strip product.

RVVTF

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Tinley’s Appoints CEO & President Of Tinley’s Brands USA And Grants Stock Options

By Vuk Zdinjak
September 16, 11:14 AM
The Tinley Beverage Company Inc. (OTCQX: TNYBF) (CSE:TNY) appointed Theodore Zittell as CEO and Richard Gillis as president, Tinley's Brands USA.

CSE:TNY

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Cannabis Life Sciences Announces Amendments To Convertible Debentures And Underlying Warrants

By Vuk Zdinjak
September 16, 10:58 AM
CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE:CLSH), a diversified cannabis company operating as Cannabis Life Sciences, announced that following receipt of the requisite approval of debenture holders and the Canadian Securities Exchange, it has amended the terms of its outstanding $13.2

CLSH

Posts pagination

Previous 1 … 392 393 394 … 449 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service